Essais liés11clinical trials
VilleCalgarylocalisation
PaysCanadalocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT02545868

Ouvrir le site du centre

Essais cliniques associés

11
MoléculeIndication / populationPhaseNCTTitreStatut
BAROSTIM NEO System Hypertension Non applicable NCT01471834 Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension ACTIVE_NOT_RECRUITING
Remote ischemic conditioning SEP Non applicable NCT06171334 Remote Ischemic Conditioning in PPMS NOT_YET_RECRUITING
THC SEP Phase 2 NCT06261489 Cannabis (THC vs. CBD) in Multiple Sclerosis RECRUITING
Emapalumab Lupus Phase 3 NCT05001737 EMERALD — Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE COMPLETED
CBD Alzheimer Phase 2 NCT06014424 CALM-IT — Cannabidiol Medication Intervention Trial RECRUITING
23-PPV SEP Phase 3 NCT02545868 A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis COMPLETED
Acoramidis Alzheimer Phase 3 NCT06563895 Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant RECRUITING
PGN-EDODM1 Myopathies Phase 2 NCT06667453 FREEDOM2-DM1 — A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 RECRUITING
SRP-1001 for Injection Myopathies Phase 1/2 NCT06131983 Study of SRP-1001 in Adult and Adolescent Participants With Facioscapulohumeral Muscular Dystrophy Type 1 RECRUITING
SRP-1003 IV Infusion Myopathies Phase 1/2 NCT06138743 Study of SRP-1003 in Participants With Type 1 Myotonic Dystrophy RECRUITING
Perindopril Alzheimer Phase 2 NCT02085265 Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients TERMINATED